Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin and Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
NCT05550415Phase 2Recruiting
- Sponsor
- Universitas Indonesia
- Start
- Aug 2022
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of simvastatin, sponsored by Universitas Indonesia. Started Aug 2022; status: recruiting.
02
Drugs
simvastatin
Beyond the preview
Go deeper on NCT05550415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05550415.